Biosimilars News
🌏 NMPANMPA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–10 of 10 articles
EirGenix Expands Japan Biosimilar Strategy at CPHI Japan 2026 Amid Regulatory Support
Samsung Bioepis Begins Phase 1 Trial for Novel ADC SBE303, Expands Sandoz Biosimilar Partnership
Mabwell Bioscience Passes First PIC/S Member GMP Inspection for Denosumab Biosimilars in Jordan
Mabwell Subsidiary T-mab Passes Jordan GMP Inspection for Denosumab Biosimilars
ICH Guidelines Biosimilar Development: Impact on APAC Approval Timelines
Biosimilar Market Growth India: Key Drivers, Challenges & Opportunities
Adalimumab Biosimilars Uptake: Australia vs Japan Market Analysis
PMDA Biosimilar Framework: Impact on Trastuzumab Biosimilars in Japan
NMPA Biosimilar Approval Pathway: What You Need to Know
Bevacizumab Biosimilar Approval China: NMPA Greenlights First Biosimilar